Advertisement

Weight-loss neurostimulation systems maker EnteroMedics gives CFO Greg Lea an additional role as COO as the company prepares to make its FDA bid.

EnteroMedics logo

Minnesota weight-loss devices maker EnteroMedics (NSDQ:ETRM) announced today that CFO and senior vice president Greg Lea had also been appointed chief operating officer.

Lea will help the company get through its 2013 objective to make progress on its pre-market approval application for the Maestro vagal blocking system, an implanted neurostimulator designed to stimulate the Vagus nerve in order to alter a patient's eating habits by modifying physiological cravings.

Advertisement
Advertisement